United States · FDA National Drug Code directory
REMICADE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-030_36afec96-dd29-9328-e063-6294a90af8e4
- Product NDC
- 57894-030
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- INFLIXIMAB
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 19980824
- Source listing expiry
- 20261231
Source-listed ingredients
- INFLIXIMAB — 100 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 BOX (57894-030-01) / 10 mL in 1 VIAL, SINGLE-USE · 57894-030-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →